Contact Information
Company Information
Company
ARENSIA Exploratory Medicine GmbH
Annual Revenue
23000000.0
Technologies
Outlook
Microsoft Office 365
Microsoft Azure Hosting
Salesforce
Ubuntu
Apache
Mobile Friendly
Facebook Custom Audiences
Facebook Widget
YouTube
Google Tag Manager
Google Maps
Facebook Login (Connect)
Keywords
first into patients phase ib sad
mad trials
proof of concept studies
phase i pk trials in patients with renal & hapatic impairment mild
moderate
severe
translational medicine
phase iia trials
adaptive design protocols
ddi trials in patients
qtc trials in patients
be studies in patients
proof of mechanism trials
phase iii trials with an exploratory
pk subgroup
research services
exploratory clinical trials
patient recruitment
phase i trials
phase ii trials
clinical research
medical trials
biotechnology
pharmaceutical companies
regulatory affairs
safety protocols
efficacy evaluation
drug development
clinical study management
patient safety
medical expertise
biostatistics
clinical pharmacology
patient demographics
patient enrollment
research clinics
clinical operations
protocol development
therapeutic areas
disease biomarkers
immuno-inflammatory diseases
cardiovascular medicine
oncology
infectious diseases
central nervous system
metabolic disorders
quality assurance
biological samples
healthcare professionals
cro collaborations
multi-center trials
clinical trial regulations
ctis submissions
clinical trial ethics
medical writing services
strategic partnerships
first-in-patient trials
adaptive design studies
biomedical research
pharmacokinetics
drug interactions
data management
patient-centric trials
innovative therapies
emergency care facilities
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans